Redmile Group, LLC, 10% Owner at ADC Therapeutics SA (ADCT), sold 5,880,415 shares at $3.75 ($19.6M) on 2026-03-31, disclosed to the SEC on 2026-04-02.
Open-market sale of $19.6M ADCT by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.75 | 188,407 | $707K | 3.6% |
| 2 | $3.75 | 196,229 | $736K | 3.7% |
| 3 | $3.80 | 162,517 | $617K | 3.1% |
| 4 | $3.80 | 169,265 | $643K | 3.3% |
| 5 | $3.28 | 2,529,491 | $8.3M | 42.2% |
| 6 | $3.28 | 2,634,506 |
| $8.6M |
| 44.0% |
| Total | $3.34 avg | 5,880,415 | $19.6M | 100% |
| Filing → |
| IGMS | BUY | 2023-07-03 | $1.5M | — | Filing → |
| IGMS | SELL | 2023-07-03 | $1.5M | — | Filing → |
| ZYME | BUY | 2022-10-18 | $153K | — | Filing → |